Skip to content
TrialScanner

NCT04641143

Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder

Phase 3CompletedBHVNLead

Registry record

Lead sponsor
Biohaven Pharmaceuticals, Inc.
Conditions
Obsessive-Compulsive Disorder
Primary completion
Oct 27, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04641143 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

1 change recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04641143: Efficacy and Safety Study of... | TrialScanner